The discovery that neuropeptides can act as neurotransmitters, neuromodulators, or hormones has had a great impact on the field of neurobiology. We are interested in understanding the role of identified neuropeptides in neuronal circuits of known function using the pulmonate mollusc, Lymnaea stagnalis. This snail has previously been used as a model system for analyzing the way in which peptides mediate simple behaviors and for studies on the structure and organization of invertebrate neuropeptide genes . In this study we describe the structure of the molluscan gene encoding the neuropeptide Phe-Met-Arg-Phe-NH, (FMRFamide) .
FMRFamide was first discovered as a cardioexcitatory agent in the Venus clam Macrocallista nimbosa (Price and Greenberg, 1977) , and although the distribution of FMRFamide itself appears to be limited to molluscs (Price, 1986) , immunoreactivity to FMRFamide has been reported in all the major animal phyla and a number of FMRFamide-like peptides have been isolated from coelenterates (Grimmelikhuijzen and Graff, 1985) , arthropods (Boer et al., 1980) , and chordates (Dockray et al., 1983; Yang et al., 1985) , indicating that FMRFamide is one of a family of related neuropeptides. However, the antibody used in many of these surveys does cross-react with other Arg-Phe-NH, peptides.
FMRFamide-like immunoreactivity has been found in a number of neurons in the CNS of Lymnaea (Schot and Boer, 1982) , and recent work using immunocytochemistry and radioimmunoassay has identified a pair of heart motoneurons whose excitatory effects on the heart appear to be due to the release of FMRFamide or a related peptide (Buckett, 1987; Benjamin et al., 1988) . The electrophysiological evidence combined with pharmacology strongly indicated that FMRFamide is the principal excitatory neurotransmitter peptide used by Lymnaea heart motoneurons. In addition, a uniquely identifiable interneuron (VWI) has been found in the Lymnaea CNS which has widespread synaptic connections with other central neurons (Benjamin, 1984) and also contains FMRFamide-like peptides (Benjamin et al., 1988) . It has been proposed that FMRFamidelike peptides might mediate these synaptic connections. While a physiological role for FMRFamide in cardioexcitation in Lymnaea is now well established, FMRFamide has a variety of actions in other systems. It has been shown to modulate the activity of specific central neurons (Stone and Mayeri, 1981) , as well as the L2 neuron (Thompson and Ruben, 1988) and R14 neuron (Ichinose and McAdoo, 1988) in Aplysia. FMRFamide causes several kinds of membrane conductance changes in the CNS (Cottrell et al., 1984; Boyd and Walker, 1985) and shortens the presynaptic action potential in sensory neurons (Abrahams et al.; 1984) . FMRFamide has also been shown to act in peripheral systems by inhibiting spontaneous activity of the gut (Austin et al., 1982) and salivary gland (Bulloch et al., 1988) . It also stimulates contractions of the buccal mass (Richmond et al., 1984) and gill (Weiss et al., 1984) in Aplysia.
FMRFamide is not the only member of this family of neuropeptides to have been shown to be present in Lymnaea. Ebberink et al. (1987) have isolated 2 heptapeptides from the central ganglia, SDPFLRFamide (Ser-Asp-Pro-Phe-Leu-ArgPhe-NH,) and GDPFLRFamide (Gly-. . . etc.) . In previous investigations of the genetic organization of families of structurally related neuropeptides, various forms have been found to be encoded by the same gene and are present on the same precursor. The question therefore arises in Lymnaea as to whether the 3 known forms of FMRFamide-related peptides are present on the same gene and/or different transcripts.
We report here on the isolation of 2 cDNA clones and a genomic clone that encode 9 copies of FMRFamide in addition to novel forms of FMRFamide-like peptides. The Lymnaea genome contains a single copy of the gene that gives rise to a unique transcript within the CNS. Our data from in situ hy-bridization suggest that the gene is expressed in specific neurons throughout the Lymnaea CNS.
Materials and Methods
Molecular procedures. General procedures such as growth of phage, Southern transfers, and plasmid preparations were carried out as described by Maniatis et al. (1982) .
Construction of oligonucleotide. Mixed oligonucleotides were synthesized on an Applied Biosystems 38 1A DNA synthesizer according to the manufacturer's instructions. The sequence of the oligonucleotide was (5' to 3') (T/C)TTNCC(A/G)AANC(G/T)CAT(A/G)AA (where N represents A, G, C, or T).
Extraction of genomic DNA. The ring of ganglia that forms the CNS (the "brain") was dissected from animals and non-neuronal tissue and mucus strands carefully removed from the ganglia using forceps. The brains were then washed in Lymnaea saline (Benjamin and Winlow, 198 1) (3 changes). The tissues (10 brains/ 100 ~1) were gently homogenized in 1 x PK buffer (Burke and Ish-Horowitz, 1982) containing 2% SDS. Two drops ofAntifoam A (Sigma) were added per 100 ~1 of buffer. This was followed by phenol extraction and ethanol precipitation of the DNA, which was found to be of high molecular weight and free from contaminating nucleases.
Isolation of FMRFamide-encoding cDNA and genomic clones. Approximately 20,000 plaques from an amplified XgtlO Lymnaea CNS cDNA library were bound to Hybond-N (Amersham) and screened with the mixed oligonucleotides labeled with +*P-ATP using T4 polvnucleotide kinase. Hvbridizations were carried out at 37°C in a solution containing 6 x SSC, 5 x Denhardt's solution, and 0.5% SDS. Filters were washed at 42°C in 6 x SSC, 0.5% SDS, dried, and autoradiographed. Two positive clones, designated Dl and D3, were obtained. When the entire EcoRI insert of Dl was subcloned into either M 13mp 18 or M 13mp 19, it was found to be unstable and readily deleted. The EcoRI inserts ofD1 and D3 were subcloned into Bluescribe (Stratagene) and subsequently digested independently with the restriction enzymes TaqI and Sau3A. The smaller fragments that this generated were ligated into M 13mpl8 and M 13mpl9 for single-strand sequencing.
To isolate a genomic clone the D3 insert was hexamer labeled (Feinberg & Vogelstein, 1983 ) and used to screen 20,000 clones of an EcoRI genomic library in Xgt 10. A positive clone containing a single insert of 4.1 kb was identified and isolated. The DNA from this clone was digested by EcoRI and BarnHI, and the resulting fragments were ligated into M13mp18 and M13mp19.
Nucleotidesequence analysis. Phage inserts, or fragments derived from them, were subcloned into either Bluescribe or M13mp18/19 vectors for sequence analysis in both orientations and were also double-strand sequenced. Sequencing using &S-dATP was performed as described by Sanger et al. (1977) or by using a commercially available kit (Sequenase, U.S. Biochemicals). The samples were separated on a 7 M urea, 6% acrylamide gel. Ambiguities were resolved bv resequencing using synthetic oligonucleotides-derived from known -sequences, 5; CCAI AGCCGGCCAGACTCGTTGGCC 3' and 5' GGAAGAGATAT-GAGTGACGTGGAC 3'.
DNA blot hybridization. Genomic DNA, 5 pg, was fully digested with a restriction enzyme and separated on a 0.5% agarose gel. The DNA was then transferred to Hybond-N (Amersham). The D3 cDNA insert was hexamer labeled in the presence of &2P-dCTP and hybridized at 65°C overnight. The filter was washed in 0.3x SSC (Maniatis et al., 1982) 0.5% wt/vol SDS, at 65°C and autoradiographed.
RNA blot hybridizations. Total RNA was isolated from 10 CNS by the standard method of homogenizing in 2 x PK buffer followed by phenol extraction. Some 10 pg of total RNA was run on a formaldehyde gel essentially as described in Maniatis et al. (1982) and transferred to Hybond-N. The D3 cDNA insert clone was hexamer labeled in the presence of olJ2P-dCTP and hvbridized to the filter at 42°C ovemiaht in 4 x SSC, 10 &ml denatured salmon sperm DNA, 0.1 x Denhardt's solution, 12.5% foramide, 10% wt/vol Dextran sulfate. The filter was washed in 2 x SSC at 60°C and then autoradiographed.
In situ hybridizations. CNS from Lvmnaea were dissected, fixed, and sectioned essentially as described by. Dirks et al. (1989) . Sections were hvbridized with c@S-dATP nick-translated D3 cDNA insert overnight af 37°C. Slides were exposed for autoradiography for 3 weeks. "
Protein sequence comparisons. et al., 1988 , and kindly donated by E. Vreugdenhil). The codon for Gly was included as this amino acid is thought to be required for amidation (Loh and Gainer, 1983) and Lys is an amino acid commonly found at a site of proteolytic cleavage within hormone precursor molecules (Douglass et al., 1984) . Approximately 20,000 recombinant clones were screened with the radiolabeled oligonucleotide from which 2 independent clones were isolated. Subsequent restriction analysis indicated that the 2 cDNAs contained inserts of 1.2 and 0.9 kb. The 2 clones were designated Dl and D3, respectively. Nucleotide sequence data revealed that both D 1 and D3 contained sequences that encode FMRFamide.
As neither cDNA included an initiator methionine that was in frame with the FMRF sequences, it was concluded that both Dl and D3 were partial cDNA clones. An additional 20,000 clones were screened with hexamer labeled Dl but no further positives were identified.
Isolation of a FMRFamide genomic clone
Southern blot analysis ( ,000 clones were screened. This resulted in the isolation of one positive phage which hybridized with Dl and D3 and was found to contain an insert of the expected size (4.1 kb). A 0.9 kb EcoRIIBamHI restriction fragment from this genomic clone was found by hybridization and sequence analysis to encode the 5' end of the cDNAs including an in frame AUG start codon.
Deduced structure of the FMRFamide mRNA preprohormone The Dl and D3 cDNAs were completely sequenced by the strategy outlined in Figure 1 . This showed that the D3 sequence was contained within D 1 and was identical except that D3 contained a run of 17As (position 986, Fig. 2 ), whereas D 1 contained 14. The overlap between the cDNA clones Dl, D3, and the genomic clone is also illustrated in Figure 1 . The longest open reading frame (ORF) in the 2 cDNA clones contained the FMRFamide sequences (Fig. 2) . There was no N-terminal methionine in either cDNA, indicating that both were partial at the 5' end. The cDNA clone Dl contains 11 nucleotides at the extreme 5' end which do not correspond to the genomic sequence. This could be a polymorphism or evidence of splicing or a cloning artifact. The first stop codon (TAA) in the FMRFamide reading frame is at position 942-944. This is followed by multiple stop codons in all 3 reading frames and a stretch of 14As starting at nucleotide 986. This is unlikely to be the posttranslational polyA tail as extra nucleotides are present 3' to this. Furthermore, from Southern analysis (data not shown) these 3' sequences are contiguous in the genome with sequences in the FMRFamide ORF. The FMRFamide ORF in the Xgt 10 genomic clone extends 5' to a stop codon at nucleotide 5 l-53, suggesting that the methionine at 82-84 is the initiating methionine. As is typical of many membrane or secreted proteins, a signal sequence containing, in this case, 6 hydrophobic T 5  TS  TS  TSS  R   I  rI   I  I  I  II  I  I  II  II  I II  I  II  II  II  II  II  III  I c * -c amino acids follows the methionine codon. This N-terminal sequence is significant (Kyte and Doolittle, 1982) as it is the only hydrophobic region in the whole precursor protein.
Interestingly, 6 hydrophobic amino acids makes the Lymnaea signal sequence the least hydrophobic of over 300 eukaryotic signal sequences recently surveyed (von Heijne, 1985 (von Heijne, , 1986 . The hydrophobic leader also conforms to the -1, -3 rule for signal peptide cleavage. Residue -1 must be small and residue -3 should not be aromatic, charged, or large and polar. In the precursor, Thr (-1) and Ala (-3) at positions 18 and 16, respectively, fulfill these criteria, predicting cleavage between Thr and Lys at amino acids 18-19. It cannot be discounted that the first potential cleavage site of Lys-Arg at positions 19-20 may act as the site for removal of the signal sequence. Nine copies of Phe-Met-Arg-Phe (FMRF) are contained on the precursor (Fig. 2) . Eight of the FMRF sequences are flanked on their amino termini by Lys-Arg, the other by Lys-Ser. The carboxy termini of the 9 FMRF sequences contain the residues Gly-Arg (4 out of 9), Gly-Lys-Ser (4 out of 9) and Gly-Lys-Arg (1 out of 9). The Gly is required for amidation of the peptides and the basic residues, which serve as proteolytic cleavage signals, are similar to those found on the Aplysia FMRFamide precursor (Taussig and Scheller, 1986) . Spacer peptides separating the 9 FMRF sequences vary in size and composition of amino acids and probably do not have any biological function other than to separate the FMRFamide sequences.
The precursor protein also contains 2 Phe-Leu-Arg-Phe (FLRF) sequences at positions 21-24 and 57-60. These sequences are flanked by a probable cleavage signal Lys-Arg on the amino termini and Gly-Arg on the carboxy termini and would therefore be amidated if cleaved from the precursor.
Other putative peptides may be contained on the precursor protein. These included the pentapeptides Gln-Phe-Tyr-Arg-Ile (QFYRI) at position 4 l-44 which was bounded by Arg-Arg and Gly-Arg at its amino and carboxy termini, respectively, and Glu-Phe-Leu-Arg-Ile (EFLRI) at position 262-266 and bounded by the cleavage signals Arg-Arg on the amino side and GlyArg on the carboxy side. These 2 pentapeptides would be amidated if processed from the precursor and glutamine if present at the amino terminal of a peptide can circularize to form pyroglutamine. This would produce pQFYRIamide and EFLRIamide.
A single gene encodes the FMRFamide precursor Genomic DNA was digested with various restriction enzymes, blotted, and probed with hexamer labeled D3 cDNA insert. The result of this Southern blot is shown in Figure 3 . Single digests with DraI, BamHI, and EcoRI when hydridized with D3 give single fragments of 1.1, 3.4, and 4.1 kb. A double digest with DraIIBamHI gives a single fragment of 1.0 kb and a double digest with BamHIIEcoRI gives 3.2 kb fragment. The observation that the BamHI site is asymmetric in the 4.1 kb EcoRI fragment which is present only once in the genome and that BamHI, which also cuts in the cDNA, produced a single fragment that hybridizes with D3, suggests that the sequence encoding D3 is present only once in the genome. Furthermore, the size of the bands was consistent with the size of the genomic fragments prepared from the EcoRI Xgt 10 genomic library, suggesting that there are no large introns in the genomic sequence.
Transcription of the FMRFamide precursor Northern blot analysis (Fig. 4) was used to indicate the number and size of transcripts produced by the FMRFamide gene in the CNS. Total RNA was isolated from 10 complete CNS, fractionated according to size, transferred to Hybond-N, and hybridized to D3 cDNA insert. The result shown in Figure 4 indicates that this gene gives rise to a unique 1.7 kb mRNA species within the CNS.
The FMRFamide gene is expressed throughout the Lymnaea CNS In order to determine more precisely the location of the FMRFamide transcripts in the CNS, in situ hybridization was performed (Fig. 5) . Preliminary analysis shows that at least 100 neurons express the FMRFamide gene and these neurons are distributed throughout the CNS.
Discussion
We have characterized 2 cDNA clones and a genomic clone that encodes 9 copies of FMRFamide, 2 copies of FLRFamide, and 2 novel pentapeptides (summarized in Fig. 6 ). We have yet to determine how many of these individual peptides are released from the precursor protein. However, the basic amino acids that serve as recognition sites for cleavage are similar to those of the Aplysia FMRFamide precursor with the exception of the LysSer seen on the amino side of one FMRFamide. Zn vivo labeling experiments using 3H-phenylalanine have indicated that most of the 28 FMRFamides encoded by the Aplysia FMRFamide gene are cleaved from the precursor (Taussig and Scheller, 1986) . Therefore, it is a reasonable assumption that most of the peptides on the Lymnaea precursor will also be cleaved. not been detected by HPLC analysis of the Lymnaea CNS (EbThe unique position (Fig. 6 ) of the 2 FLRFamide peptides in berink et al., 1986) . A similar situation arose in Aplysia where the Lymnaea precursor suggests that they have some biological FLRFamide remained undetected by HPLC analysis (Lehman function and are not just simple methionine-leucine substituet al., 1984) but was later found to be present on the FMRFamide tions. The substitution of a leucine for a methionine may confer precursor by sequencing ofa cDNA (Taussig and Scheller, 1986) .
greater stability on the peptide as leucine is less susceptible to oxidation than methionine. This greater stability may be important in the potential hormonal actions of FLRFamide (Price, 1986) .
Lymnaeu has also been shown to possess 2 amino terminally extended forms of FLRFamide, SDP-and GDPFLRFamide. Extensions at the amino terminal may give the peptide even greater stability by protecting against enzymatic degradation. The fact that the N-terminal-extended FLRFamides are not present in the FMRFamide precursor protein supports the proposition of Price (1986) that after a duplication of the ancestral FMRFamide gene, one gene became specialized for the production of transmitters (FMRFamide) and the other for the production of extended FMRFamide hormones.
The 2 pentapeptides, pQFYRIamide and EFLRIamide, are previously unreported. They are bounded by basic amino acid cleavage signals and therefore likely to be processed.
The Northern blot analysis indicated that there is only one mRNA produced. Therefore, any neurons that express the FMRFamide gene are likely to synthesize the precursor, so any differential usage of the peptides probably occurs as a result of posttranslational processing. Comparison of the Aplysia CRF-like peptide with the corresponding Lymnaea sequences The Aplysia FMRFamide precursor was reported to contain sequences that are homologous to mammalian brain peptide sequences, including corticotropin-releasing factor (CRF); oc-melanocyte-stimulating hormone (orMSH), and corticotropinlike intermediate-lobe peptide (CLIP) (Taussig and Scheller, 1986) . positional matches out of 42. However, the degree of homology between the Lymnaea sequence and any of the vertebrate peptides is even less than that of the ApZysia CRF-like peptide and the vertebrate peptides. Taussig et al. (1988) concluded that if the Aplysia CRF-like peptide was indeed related to the vertebrate CRFs, then there would have been an amino acid substitution every 17.5 million years on the average. On this basis, the degree of divergence between Lymnaea and Aplysia sequences over the 350 million years since their divergence (Moore and Pitrat, 1960) should be 22 out of 42. The observed difference is 17, indicating that this is a good approximation to what is expected. The degree of homology throughout the 42 amino acids however is not uniform. There is a sequence (79-89) of Ser-Glu-Glu-Pro-Leu-TyrArg-Lys-Arg-Arg that is 100% homologous between the 2 molluscan species and is 79% homologous at the nucleotide level. This exceptionally high level of conservation indicates that this sequence may have some functional importance. The tetra basic sequence Arg-Lys-Arg-Arg is reminiscent of the Arg-Lys-ArgArg sequence in the Aplysia ELH prohormone (Scheller et al., 1983) . The processing of this prohormone has been studied by Fischer et al. (1988) who suggest that this sequence is the first to be recognized and cleaved. The tetra basic cleavage site may not only serve to generate this novel peptide but could also be important in the differential processing of the precursor by separating the FLRFamide and FMRFamides.
The Lymnaea precursor, unlike that of Aplysia, has no sequences with any significant homology to either vertebrate arMSH or CLIP. Apparent homology between the mammalian CLIP peptide and the Aplysia sequence residues 20-42 has been sug- Figure 7 . Comparison of Lymnueu CRF-like peptide with the analogous sequence in the Aplysiu Fh4RFamide precursor, ovine CRF, frog sauvagine, carp urotensin and the CRF-like sequence in the Drosophila precursor. Bold letters show amino acids conserved between Lymnaeu and Aplysiu, and asterisks show amino acids in Lymnueu CRF which are in common with CRF from at least one other organism other than Aplysiu. Sequences from Taussig and Scheller (1986) and Schneider and Taghert (1988). gested (Taussig and Scheller, 1986) . Comparison of the same region in Lymnaea (amino acids 15-37) shows that only amino acids serine (15), valine (17) threonine (18), and arginine (36) are conserved between Lymnaea and Aplysia, and only valine (17) is common to all 3 sequences. The 15 amino acid otMSHlike sequence in Aplysia (45-59) corresponds to Lymnaea 40-48, a 9-amino acid region containing a run of 6 gaps which are required to maximize alignment in the first 100 amino acids of the sequence. There is therefore no sequence of any significant homology of (wMSH. Previously, the only other molluscan FMRFamide precursor to be examined at the genetic level is that of Aplysia (Schaefer et al., 1985; Taussig and Scheller, 1986) . The most striking feature of that precursor protein is its highly repeated nature. This is especially true between the 7th FMRFamide and the 26th, where the FMRFamide and its spacer is composed of 15 or 16 amino acids. Many of these sequences are identical at the amino acid level, and several show high homology at the nucleotide level. The repeated nature of the Aplysia FMRFamide precursor led Price et al. (1987) to speculate on the origin of the precursor. They proposed a model to show how the modem opisthobranch gene could have arisen from a hypothetical pulmonate gene. They concluded that these highly repeated sequences could have arisen from an intragenic duplication event; presumably by the sequences encoding the 7th FMRFamide and its spacer being amplified 19 times. With the removal of this iterative portion of the Aplysia precursor, a model of the ancestral precursor may be generated. In ApZysia this would contain 9 FMRFamides, 1 FLRFamide, and the "vertebrate"-like peptides. In this respect, it should be noted that the Lymnaea gene contains 9 FMRFam- (Lipman and Pearson, 1985 (Schneider and Taghert, 1988) .
A comparison of the Lymnaea and Aplysia amino acid sequence around 2 of the novel Lymnaea predicted peptides suggests how these novel peptides may have arisen (Fig. 8) . The predicted peptide Gln-Phe-Tyr-Arg-Ile-NH, corresponds to the region of Aplysia encoding the cYMSH-like peptide. It is possible that this sequence was present in Lymnaea at one time and a deletion and some substitutions gave rise to the new sequence. The other novel predicted peptide Glu-Phe-Leu-Arg-Ile-NH, could have arisen from a FMRFamide sequence as a result of substitutions.
However, it is difficult to be certain of the alignment of one member of the FMRFamide multipeptide family with another for the purposes of comparison.
It will be interesting to determine the processing and physiological role of the novel peptides in Lymnaea, and therefore to determine whether such peptides have been subject to natural selection or are simply neutral changes of little or no physiological consequence.
Note added in prooj We now have evidence that the 11 nucleotides unique to Dl may be the result of RNA splicing.
